Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
Stroke Trial Links
Government Sites
Independent Sites
News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback
Search for Trials
PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Epoetin Alfa
Procrit and Epogen

Action
Used to treat anemia, to decrease the need for red blood cell transfusions. Usually given by subcutaneous injection.

Status
FDA approved

Trial(s)
  = Ongoing
  = Completed

ESS Double-Blind, Placebo-Controlled Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke
REGENESIS(CA) REGENESIS: A Phase II Prospective, Randomized, Double-Blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients
Treating Patients With Aneurysmal SubArachnoid Hemorrhage With Epoetin Alfa

Web Links and Publications
Medline Plus
This information last updated on: 02/29/2008

UID: 247

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2009 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, November 20, 2009